Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pharmaceutics International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011825
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmaceutics International Inc (PII) is a contract development and manufacturing company that offers dosage form development and cGMP manufacturing services. The company offers manufacturing of drugs such as dosage forms of solid, semi-solid, liquid, inhalation, parenteral and aseptic filling. Its services comprise drug substance optimization, preformulation testing, dosage form development, CTM manufacturing, commercial manufacturing, clinical packaging and labeling, clinical trial kit building and distribution, among others. PII also offers API characterization and solid state screening, dosage form development, pre-formulation testing, CTM manufacturing and commercial manufacturing programs. The company serves its clients in the US and abroad. PII is headquartered in Hunt Valley, Maryland, the US.

Pharmaceutics International Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pharmaceutics International Raises USD10 Million in Venture Financing 10
Pharmaceutics International Raises USD93 Million in Venture Financing 11
Partnerships 13
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 13
Pharmaceutics International Inc – Key Competitors 14
Pharmaceutics International Inc – Key Employees 15
Pharmaceutics International Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Legal and Regulatory 17
Sep 16, 2016: Pharmaceutics International US: supply of non-critical medicines to EU to be stopped due to manufacturing failings 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmaceutics International Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pharmaceutics International Raises USD10 Million in Venture Financing 10
Pharmaceutics International Raises USD93 Million in Venture Financing 11
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 13
Pharmaceutics International Inc, Key Competitors 14
Pharmaceutics International Inc, Key Employees 15
Pharmaceutics International Inc, Other Locations 16

★海外企業調査レポート[Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hepregen Corporation(製薬・医療分野):企業M&A動向
    Summary Hepregen Corporation (Hepregen) is a biotechnology company. The company develops alternative to liver transplantation for patients. Its products include human hepatopac kit, rat hepatopac kit, monkey hepatopac kit, dog hepatopac kit, and multi species kit. Its products contain human co cultu …
  • Phase Focus Limited:(医療機器分野)企業M&A及び提携動向
    Summary Phase Focus Limited (Phase Focus) is a medical technology company. The company provides products and services based on its PhaseFocus Virtual Lens technology. Its PhaseFocus Virtual Lens is a method for quantitative imaging and microscopy. Phase Focus’s technology eliminates the distortions, …
  • Seven Principles AG (T3T):企業概要、財務及び戦略的SWOT分析
    Summary Seven Principles AG (7P) is an information technology company. The company provides enterprise mobility services. Its services include IT consulting, process management, information management, cloud services, mobile solutions, SAP services, software solutions, and quality management. 7P off …
  • DVx Inc (3079):企業財務及び戦略的SWOT分析
    Summary DVx Inc (DVx) is a medical device company that offers internal and external medical device. The company’s products include pacemakers, ICDs, electrode catheters, ablation catheters, ACIST CVi, excimer laser, lapis blue, RADPAD RADCAP RADNEK, resolution and resolution SD, and wonder belt. It …
  • Albany Molecular Research, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Albany Molecular Research, Inc. …
  • McLeod Russel India Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' McLeod Russel India Limited Mer …
  • Five Prime Therapeutics Inc (FPRX):企業財務及び戦略的SWOT分析
    Summary Five Prime Therapeutics Inc (Five Prime) is a biotechnology company that focuses on discovery and development of protein therapeutics. The company offer wide range of products for cancer, inflammatory disorders, muscle disease and other conditions. Five Prime develops proprietary protein scr …
  • Ingena Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ingena Group Limited Mergers an …
  • Harman International Industries, Incorporated:企業のM&A・提携・投資分析
    Harman International Industries, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harman International Industries, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • NextEra Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NextEra Energy, Inc. Mergers an …
  • Sudarshan Chemical Industries Limited (SUDARSCHEM):企業財務及び戦略的SWOT分析
    Summary Sudarshan Chemical Industries Limited (Sudarshan Chemical) is a chemical company that develops and markets pigments and colors. The company offers products such as organic and inorganic pigments, mica-based effect pigments, chemical intermediates and pesticides. It provides products of diffe …
  • Black Duck Software, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Black Duck Software, Inc. Merge …
  • SQI Diagnostics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SQI Diagnostics, Inc. Mergers a …
  • Essilor International S.A.:企業の戦略・SWOT・財務分析
    SummaryEssilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Evolving Systems, Inc. (EVOL):企業の財務及び戦略的SWOT分析
    Summary Evolving Systems, Inc. (Evolving Systems) is an information technology company that provides development, delivering and supporting technology and vendor independent software solutions. The company offers software solutions such as dynamic SIM allocation, mobile data enablement, service acti …
  • Marvelous, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Marvelous, Ltd. Mergers and Acq …
  • Aethlon Medical, Inc. (AEMD):企業のM&A・提携動向(医療機器分野)
    Summary Aethlon Medical, Inc. (Aethlon Medical) develops devices to treat cancer, infectious disease and other life-threatening conditions. The company’s lead product, Hemopurifier primarily addresses anti-viral drug resistance in Human Immunodeficiency Virus and Hepatitis C Virus infected patients. …
  • Ozu Corporation (7487):企業財務及び戦略的SWOT分析
    Summary Ozu Corporation (Ozu) is a non-woven fabric company that offers non-woven fabric, paper and non-woven paper products. The company's products include cotton gauze, cosmetic face mask, cotton wool pad, peracetic acid-based disinfectant wiper, sterile formulation related products, wet tissue, t …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務分析
    SummaryJubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view o …
  • Sam-A Pharm. Co., Ltd. (009300):企業概要、財務及び戦略的SWOT分析
    Summary Sam-A Pharm is a pharmaceutical company. The company develops and manufactures various pharmaceutical products. It operates through product categories ETC, OTC and noma. Sama Pharm’s ETC products include respiratory, anti-biotics, anti-virals, anti-fungals, dermatology, pain/inflammation, ga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆